Transfusion as supportive care for the improvement of the quality of life.

Transfusion as supportive care.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20749

Enrollment

100

Registered

2011-01-05

Start date

2011-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patiënts with a chronic need for bloodtransfusion due to e.g. myelodysplatic syndrome, myelofibrosis or myeloproliferative conditions.

Interventions

Transfusion with either: 1. 1 erythrocyte concentrate

2. 2 erythrocyte concentrate.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Need for chronic transfusion; 2. 18-85 years; 3. Patient is fully competent; 4. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Chemotherapy; 2. Extra-medullary hematopoiesis; 3. Language barrier.

Design outcomes

Primary

Measure	Time frame
Quality of life assesed with the EORTC QLQ C-30 questionnaire.	—

Secondary

Measure	Time frame
1. Number of transfusion units; 2. Transfusionfrequency; 3. Average Hb concentration before transfusion; 4. Number and duration of hospital visits.	—

Contacts

Public ContactA.W. Duyts

Medisch Spectrum Twente Postbus 50.000

a.duyts@MST.nl+31 (0)53 4872000

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)